Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary S… (NCT06723470) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary School Children
90 participantsStarted 2024-12-15
Plain-language summary
This is an observational study that aims to understand the effects of passive smoking (secondhand smoke exposure) on children's health and development. The main question the study seeks to answer is:
How does exposure to secondhand smoke affect the physical fitness, cognitive abilities, and academic performance of primary school children?
The study will compare two groups of children aged 6-11 years: one group exposed to secondhand smoke at home (due to parents or caregivers who smoke) and another group not exposed to secondhand smoke. The children's physical capacity, cognitive skills, and school performance will be assessed through various tests.
The goal of the study is to provide valuable insights into how secondhand smoke may negatively impact children, helping families, schools, and healthcare providers understand the risks and promote healthier, smoke-free environments for children.
Who can participate
Age range
6 Years – 11 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Children aged 6-11 years, enrolled in primary school.
. Both genders (male and female).
. Healthy children with no musculoskeletal, visual, auditory, or cognitive impairments.
. Children whose parents have been smoking for at least 6 years, with moderate to high smoking levels (based on the smoking index).
. Children residing in a moderate socioeconomic status.
. Children living in Cairo, Egypt.
. Children who are able to follow simple commands and participate in assessments.
Exclusion criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Impact of Passive Smoking on Functional Capacity in Primary School Children
. Children with musculoskeletal problems, congenital deformities, visual or auditory defects, learning disabilities, or autism.
. Children who are currently taking medications that affect alertness or cognitive function.
. Children who are not exposed to secondhand smoke (non-smokers) but have parents who smoke at very low levels or do not meet the inclusion criteria for passive smoking exposure.
. Children who are unable to cooperate or participate in the assessments.